Page last updated: 2024-08-24

3-iodobenzylguanidine and Cancer of Duodenum

3-iodobenzylguanidine has been researched along with Cancer of Duodenum in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hamada, T; Hisatome, I; Igawa, O; Ishiguro, K; Ishiguro, S; Kaetsu, Y; Miake, J; Mizuta, E; Nawada, T; Peili, L; Shigemasa, C; Shimoyama, M; Taniguchi, S1
Adenis, A; Cortot, A; Houcke-Lecomte, M; Mudry, J; Paris, JC; Plane, C; Ythier, H1

Other Studies

2 other study(ies) available for 3-iodobenzylguanidine and Cancer of Duodenum

ArticleYear
Small extra-adrenal pheochromocytoma causing severe hypertension in an elderly patient.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2006, Volume: 29, Issue:8

    Topics: 3-Iodobenzylguanidine; Aged; Duodenal Neoplasms; Female; Humans; Hypertension; Iodine Radioisotopes; Pheochromocytoma; Radionuclide Imaging

2006
[Duodenal dopaminoma marked by meta-iodobenzylguanidine labelled with Iodine 131].
    Gastroenterologie clinique et biologique, 1988, Volume: 12, Issue:12

    Topics: 3-Iodobenzylguanidine; Adult; Dopamine; Duodenal Neoplasms; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Radionuclide Imaging

1988